Goodizine L Tablet contains Levocetirizine 5 mg, a third-generation non-sedative antihistamine used primarily for the relief of allergic symptoms. Levocetirizine is the active enantiomer of cetirizine and functions as a selective antagonist of peripheral histamine H1 receptors, thereby inhibiting the effects of histamine released during allergic reactions. This medication is indicated for the treatment of allergic rhinitis, including seasonal and perennial forms, as well as chronic idiopathic urticaria characterized by itching and hives. Goodizine L Tablet provides rapid onset of action with sustained efficacy over 24 hours, improving patient compliance with once-daily dosing. It is generally well tolerated, with a low incidence of sedation and minimal anticholinergic effects compared to first-generation antihistamines. The drug is metabolized minimally in the liver and primarily excreted unchanged via the kidneys, necessitating dose adjustments in patients with renal impairment. Contraindications include hypersensitivity to levocetirizine or any component of the formulation. Caution is advised in patients with severe renal dysfunction. Common adverse effects may include headache, dry mouth, and fatigue, though these are typically mild and transient. Goodizine L Tablet should be used under medical supervision, with adherence to prescribed dosage to ensure optimal therapeutic outcomes.